FUNDING AREAS: Cancer, HIV/AIDS, hepatitis, Type 2 Diabetes, and mental health
CONTACT: firstname.lastname@example.org, 609-252-3390
IP TAKE: Doykos has been with the Bristol-Myers Squibb Foundation for more than 15 years, and she has amassed a strong, institutional knowledge in that time. Her funding interest: projects that make marginalized communities healthier.
PROFILE: The Bristol-Myers Squibb Foundation wants to reduce health disparities around the world. A noble —if ambitious—goal. Directing the foundation in promoting wellness among underprivileged groups in America and abroad is Patricia Mae Doykos.
Typically, non-profit program officers don't have their wedding announcements published in the New York Times. Not so for Doykos. When she married her husband, then a young law firm associate, in 1991, Doykos' parents published the good news in New York's paper of record. In the description of the happy couple, we learn that Doykos graduated from Phillips Academy in Andover, Massachusetts, Dartmouth College, and the University of Virginia with a master's degree in German studies. We also learn that Doykos's father was a professor of pediatric dentistry at Harvard. Doykos grew up in a family that valued health and education, and she has gone on to a career brings these important assets to people who didn't necessarily go to prep school as children. And good for her.
Bristol-Myers Squibb has assets of more than $151 million and gives away about $28 million in grants annually. The foundation's major areas of focus are cancer in Europe, HIV/AIDS in Africa, hepatitis in Asia, and Type 2 Diabetes and mental health in the United States. Bristol-Myers Squibb has a global presence in the health charity world, but like many other foundations dealing with health, it recognizes that it has important work to do stateside as well.
In addition to being foundation director, Doykos is the point person for Bristol-Myers Squibb's Together on Diabetes initiative. The multimillion, multiyear project works in more than 50 communities throughout the United States to help diabetes patients manage their care. Diabetes is one of those chronic diseases that can be treated but not cured, and regular management, both in the doctor's office and at home, is crucial. But Type 2 Diabetes, often a function of poor nutrition, disproportionately affects populations that have reduced access to health care. Which is where foundations like Bristol-Myers Squibb come in: to fill in gaps in the safety net for America's sick and impoverished.
Groups interested in obtaining funding from Bristol-Myers Squibb can find information on the grant-giving process here. Key takeaways for potential grantees: Be a nonprofit, and be engaged in projects relating to the foundation's core funding areas.
Doykos has been with Bristol-Myers Squibb for some time. She joined the foundation in 1997 and has worked in various capacities on a number of public health issues, including HIV/AIDS, women's health, cardiac health, arthritis, and substance abuse. Before coming on board with the foundation, Doykos worked for five years on Bristol-Myers Squibb's corporate side, promoting products around the globe that would treat cancer or infectious diseases. Also worth noting: Doykos continued to pursue her interest in German affairs after receiving that master's degree noted above. After she got married, Doykos earned her Ph.D. in German literature and cultural studies from New York University.